PREMIER BIOMEDICAL INC Contracts & Agreements
86 Contracts & Agreements
- Business Finance (63 contracts)
- Human Resources (3)
- Intellectual Property (6)
- Uncategorized (14)
- DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THEEXCHANGE ACT (Filed With SEC on May 15, 2020)
- Technology Acquisition and Financing Agreement dated May 8, 2020 (Filed With SEC on May 14, 2020)
- Intellectual Property Agreement dated May 12, 2020 (Filed With SEC on May 14, 2020)
- Third Addendum to License Agreement with Marv Enterprises, LLC dated May 11, 2020 (Filed With SEC on May 14, 2020)
- Equity Purchase Agreement dated October 3, 2019 with Green Coast Capital International SA (Filed With SEC on October 9, 2019)
- Registration Rights Agreement dated October 3, 2019 with Green Coast Capital International SA (Filed With SEC on October 9, 2019)
- Convertible Promissory Note dated October 3, 2019 with Green Coast Capital International SA (Filed With SEC on October 9, 2019)
- 8% Convertible Promissory Note in the principal amount of $60,000 issued July 11, 2018 to SEG-RedaShex LLC (Filed With SEC on November 26, 2018)
- 8% Convertible Promissory Note in the principal amount of $120,000 issued July 11, 2018 to RedDiamond Partners LLC (Filed With SEC on November 26, 2018)
- Form of 8% Convertible Promissory Note, dated March 1, 2018 (Filed With SEC on April 12, 2018)
- Securities Purchase Agreement dated March 1, 2018, by and among the Company, RedDiamond Partners LLC and SEG-RedaShex, LLC (Filed With SEC on April 12, 2018)
- Registration Rights Agreement dated March 1, 2018, by and among the Company, RedDiamond Partners LLC and SEG-RedaShex, LLC (Filed With SEC on April 12, 2018)
- Form of Exchange Agreement, dated August 4, 2017 (Filed With SEC on November 21, 2017)
- Form of 8% Convertible Promissory Note, dated August 8, 2017 (Filed With SEC on November 21, 2017)
- Amendment No. 1 of the Registration Rights Agreement, dated August 4, 2017 (Filed With SEC on November 21, 2017)
- Amendment No. 1 of the Securities Purchase Agreement, dated August 8, 2017 (Filed With SEC on November 21, 2017)
- Form of 8% Convertible Promissory Note (Filed With SEC on October 16, 2017)
- Form of 8% Convertible Promissory Note (Filed With SEC on October 4, 2017)
- Form of Exchange Agreement, dated August 4, 2017 (Filed With SEC on August 21, 2017)
- Form of 8% Convertible Promissory Note, dated August 8, 2017 (Filed With SEC on August 21, 2017)
- Amendment No. 1 of the Registration Rights Agreement, dated August 4, 2017 (Filed With SEC on August 21, 2017)
- Amendment No. 1 of the Securities Purchase Agreement, dated August 8, 2017 (Filed With SEC on August 21, 2017)
- Form of Series A Common Stock Purchase Warrant (Filed With SEC on May 26, 2017)
- Form of Series B Common Stock Purchase Warrant (Filed With SEC on May 26, 2017)
- Form of Securities Purchase Agreement (Filed With SEC on May 26, 2017)
- Form of Registration Rights Agreement (Filed With SEC on May 26, 2017)
- Form of Series A Common Stock Purchase Warrant (Filed With SEC on May 18, 2017)
- Form of Series B Common Stock Purchase Warrant (Filed With SEC on May 18, 2017)
- Form of Securities Purchase Agreement (Filed With SEC on May 18, 2017)
- Form of Registration Rights Agreement (Filed With SEC on May 18, 2017)
- WARRANT PURCHASE AGREEMENT (Filed With SEC on October 14, 2016)
- EXCHANGE AGREEMENT (Filed With SEC on October 14, 2016)
- 10% CONVERTIBLE PROMISSORY NOTE DUE OCTOBER 10, 2017 (Filed With SEC on October 14, 2016)
- STOCK PURCHASE AGREEMENT (Filed With SEC on June 3, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 3, 2016)
- 10% CONVERTIBLE PROMISSORY NOTE DUE FEBRUARY 27, 2017 (Filed With SEC on June 3, 2016)
- 10% CONVERTIBLE PROMISSORY NOTE DUE DECEMBER 11, 2016 (Filed With SEC on March 16, 2016)
- 10% CONVERTIBLE PROMISSORY NOTE DUE DECEMBER 11, 2016 (Filed With SEC on March 15, 2016)
- FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 11, 2016)
- SECOND AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 11, 2016)
- 10% CONVERTIBLE PROMISSORY NOTE DUE DECEMBER 7, 2016 (Filed With SEC on March 11, 2016)
- 10% CONVERTIBLE PROMISSORY NOTE DUE NOVEMBER 22, 2016 (Filed With SEC on March 3, 2016)
- 10% CONVERTIBLE PROMISSORY NOTE DUE October 8, 2016 (Filed With SEC on January 12, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 31, 2015)
- 10% CONVERTIBLE PROMISSORY NOTE DUE SEPTEMBER 28, 2016 (Filed With SEC on December 31, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 31, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 23, 2015)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 23, 2015)
- BIEI TERM SUMMARY CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 9, 2015)
- PREMIER BIOMEDICAL, INC. (Filed With SEC on August 14, 2015)
- CONSULTING AGREEMENT (Filed With SEC on July 9, 2015)
- COMMON STOCK PURCHASE WARRANT (Filed With SEC on May 15, 2015)
- PATENT LICENSE AGREEMENT (UTEP AND PREMIER BIOMEDICAL, INC.) (Filed With SEC on March 18, 2015)
- PREMIER BIOMEDICAL, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on March 6, 2015)
- EXHIBIT 10.4 AMENDMENT (Filed With SEC on March 6, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 4, 2015)
- EXHIBIT 10.2 (Filed With SEC on March 4, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 4, 2015)
- EXHIBIT 10.2 (Filed With SEC on February 4, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 2, 2014)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 2, 2014)
- PREMIER BIOMEDICAL, INC. DIRECTORS BRIDGE LOAN AGREEMENT PROMISSORY NOTE $50,000.00November 18, 2013 (the Issue Date)El Paso, TX (Filed With SEC on December 10, 2013)
- INVESTMENT AGREEMENT (Filed With SEC on December 10, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 10, 2013)
- FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 12, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 28, 2013)
- Principal Amount: $26,500.00Original Issue Date: August 13, 2013Purchase Price: $26,500.00 CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 28, 2013)
- PREMIER BIOMEDICAL, INC. (Filed With SEC on April 1, 2013)
- DIRECTORS STOCK PURCHASE AGREEMENT (Filed With SEC on February 27, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 10, 2012)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 10, 2012)
- COLLABORATIVE AGREEMENT (Filed With SEC on May 14, 2012)
- FIRST ADDENDUM TO LICENSE AGREEMENT (Filed With SEC on October 4, 2011)
- FIRST ADDENDUM TO LICENSE AGREEMENT (Filed With SEC on October 4, 2011)
- LICENSE AGREEMENT (Filed With SEC on June 14, 2011)
- LICENSE AGREEMENT (Filed With SEC on June 14, 2011)
- PREMIER BIOMEDICAL, INC. (Filed With SEC on June 14, 2011)
- PREMIER BIOMEDICAL, INC. (Filed With SEC on June 14, 2011)
- PREMIER BIOMEDICAL, INC. (Filed With SEC on June 14, 2011)
- PREMIER BIOMEDICAL, INC. (Filed With SEC on June 14, 2011)
- PREMIER BIOMEDICAL, INC. (Filed With SEC on June 14, 2011)
- PROMISSORY NOTE (Filed With SEC on June 14, 2011)
- PROMISSORY NOTE (Filed With SEC on June 14, 2011)
- PROMISSORY NOTE (Filed With SEC on June 14, 2011)
- PROMISSORY NOTE (Filed With SEC on June 14, 2011)
- PREMIER BIOMEDICAL, INC. (Filed With SEC on June 14, 2011)